A Phase I Clinical Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Trial Profile

A Phase I Clinical Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs DSP 7888 (Primary)
  • Indications Acute myeloid leukaemia; Glioblastoma; Malignant melanoma; Myelodysplastic syndromes; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Renal cell carcinoma; Sarcoma
  • Focus Adverse reactions
  • Sponsors Boston Biomedical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Dec 2016 Planned number of patients changed from 60 to 76.
    • 16 Dec 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top